Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, Australia
Dermatology · 2025
DOI: 10.1159/000540455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology, 2025. Verfasst von James Pham und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Cutaneous Medicine, Ingham Institute for Applied Medical Science, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Mass Screening. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with significant patient burden and impact on quality of life. Australia has a population of over 25 million people, with an estimated 29% of people born overseas. Previous studies have estimated the prevalence of HS in Australia to be approximately 0.67%, but methodological issues limit the accuracy of this estimate. This study was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative, aiming to objectively quantify the prevalence of HS in Australia.
Methods
The methodology followed the previously published GHiSA methodology. A validated questionnaire was used to identify patients likely to have a diagnosis of HS. Screen-positive patients as well as a selection of screen-negative patients underwent clinical examination by a single physician experienced in the identification, diagnosis and management of HS to further validate the sensitivity and specificity of the questionnaire.
Results
A total of 1,657 eligible healthy accompanying adults were approached, of whom 1,002 consented for inclusion in the study (60.5%). A total of 9 were survey screen-positive for HS, representing a prevalence of 0.9% (95% CI: 0.5%–1.7%).
Conclusions
This single tertiary referral center study identified an HS prevalence of 0.9% in Australia. The methods address the deficiencies in other methodologies and provide insight into the prevalence of HS globally as part of the GHiSA initiative.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Translational Cutaneous Medicine, Ingham Institute for Applied Medical Science, Sydney, New South Wales, Australia.
- Department of Dermatology, Liverpool Hospital, Sydney, New South Wales, Australia.
- School of Clinical Medicine, UNSW Medicine and Health, Sydney, New South Wales, Australia.
- Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
- Department of Clinical Medicine, Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.
- Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Zitieren
APA
Pham, J., Flora, A., Kozera, E. K., Medianfar, C. E., Bouazzi, D., Christensen, R., Jemec, G. B. E., & Frew, J. W. (2025). Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, Australia. Dermatology. https://doi.org/10.1159/000540455
Vancouver
Pham J, Flora A, Kozera EK, Medianfar CE, Bouazzi D, Christensen R, et al. Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, Australia. Dermatology. 2025. doi:10.1159/000540455
BibTeX
@article{Pham2025,
author = {Pham, James and Flora, Akshay and Kozera, Emily Kay and Medianfar, Cecilia E and Bouazzi, Dorra and Christensen, Robin and Jemec, Gregor B E and Frew, John W},
title = {Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, Australia},
journal = {Dermatology},
year = {2025},
doi = {10.1159/000540455}
}
EUVIMED